DexCom Inc (DXCM)

Operating profit margin

Dec 31, 2023 Sep 30, 2023 Jun 30, 2023 Mar 31, 2023 Dec 31, 2022 Sep 30, 2022 Jun 30, 2022 Mar 31, 2022 Dec 31, 2021 Sep 30, 2021 Jun 30, 2021 Mar 31, 2021 Dec 31, 2020 Sep 30, 2020 Jun 30, 2020 Mar 31, 2020 Dec 31, 2019 Sep 30, 2019 Jun 30, 2019 Mar 31, 2019
Operating income (ttm) US$ in thousands 597,700 506,200 448,200 397,100 391,200 266,400 237,200 261,200 265,800 369,200 345,000 311,800 299,500 297,000 258,900 190,300 142,300 -123,800 -165,900 -170,000
Revenue (ttm) US$ in thousands 3,603,200 3,380,700 3,175,600 3,001,700 2,889,200 2,740,300 2,599,600 2,478,000 2,333,800 2,206,500 2,058,200 1,914,400 1,823,900 1,754,600 1,659,800 1,555,100 1,426,800 1,302,000 1,187,500 1,108,600
Operating profit margin 16.59% 14.97% 14.11% 13.23% 13.54% 9.72% 9.12% 10.54% 11.39% 16.73% 16.76% 16.29% 16.42% 16.93% 15.60% 12.24% 9.97% -9.51% -13.97% -15.33%

December 31, 2023 calculation

Operating profit margin = Operating income (ttm) ÷ Revenue (ttm)
= $597,700K ÷ $3,603,200K
= 16.59%

Dexcom Inc's operating profit margin has shown a positive trend over the past eight quarters, indicating improving efficiency in generating profits from its core operations. The company's operating profit margin increased steadily from Q1 2022 to Q4 2023, with a notable uptick in the last two quarters. This performance suggests that Dexcom has been successful in controlling its operating expenses relative to its revenue, leading to higher profitability. The latest operating profit margin of 16.55% in Q4 2023 reflects a strong financial position and efficient management of operational costs. Overall, the increasing trend in operating profit margin is a positive indicator of Dexcom's operational efficiency and profitability.


Peer comparison

Dec 31, 2023


See also:

DexCom Inc Operating Profit Margin (Quarterly Data)